Kewaunee Scientific

KEQU

Market cap $104M

KEQU posts lower Q4 sales and EPS as project timing and Middle East shipment delays weigh on the results despite annual revenue growth.

STATESVILLE, N.C., June 23, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its fiscal year and fourth quarter ended April 30, 2026.

STATESVILLE, N.C., June 10, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release financial results for its fourth quarter and fiscal year ended April 30, 2026 on Tuesday, June 23, 2026 after the close of trading.

STATESVILLE, N.C., April 14, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced the appointment of Jorge Santos as VP – International Sales – Lab Products Group, further strengthening the Company's commercial leadership as it accelerates growth in key global markets.

KEQU posts modest sales growth in Q3 but a sharp profit decline, with domestic weakness offset partly by strong international performance.

STATESVILLE, N.C., March 11, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2026.

STATESVILLE, N.C., March 3, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company will attend the 2026 analytica tradeshow and conference, taking place in Munich from March 24-27.

STATESVILLE, N.C., Feb. 25, 2026 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2026 financial results on Wednesday, March 11, 2026 after the close of trading.

KEQU posts sharp Q2 sales growth, driven by strong backlog and Nu Aire, but earnings decline amid project timing volatility and higher costs.

STATESVILLE, N.C. , Dec. 10, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2025.